On November 6, President Donald Trump announced the GENErating cost Reductions fOr U.S
"We remind people to be extremely cautious of unknown overseas websites selling medicines," the Ministry of Health spokesperson said
The primary one is competition from other GLP-1 drugs, especially from Eli Lillys Mounjaro (tirzepatide), which has shown greater efficacy in weight loss and diabetes control
Retatrutide, a new peptide in clinical trials, shows strong weight-loss potential by targeting three hormone pathways, but raises concerns about side effects, and mental health impact
In order to improve the medication compliance of diabetic patients, polylactic-co-glycolic acid (PLGA) was used to wrap exenatide drug, which has sustained-release effect, and the half-life is as long as 5-6 days